Oak Grove Capital’s Zimmer Biomet ZBH Stock Holding History

Oak Grove Capital’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-55	Closed	-$6K	–	181
2018 Q1	$6K	Buy	+55	New	+$6.39K	0.01%	132

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Nordea Investment Management Stockholm, Sweden $107B AUM 24.58% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Oak Grove Capital's ZBH Position: Q2 2018 in Review

Oak Grove Capital sold out of Zimmer Biomet (ZBH) in Q2 2018, closing a stake of 55 shares — an estimated $6K sold.

Oak Grove Capital first reported a position in ZBH in Q1 2018 and held it in 1 quarter. The position peaked at $6K in Q1 2018. 869 funds tracked by Wall St. Rank hold ZBH as of Q2 2018.

Oak Grove Capital reported no remaining Zimmer Biomet position as of Q2 2018 after selling out during the quarter.
Oak Grove Capital sold 55 Zimmer Biomet shares in Q2 2018, an estimated $6K.
Oak Grove Capital first reported a position in Zimmer Biomet in Q1 2018 and held it in 1 quarter.
Oak Grove Capital's Zimmer Biomet position peaked at $6K in Q1 2018.
869 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2018.

Based on Oak Grove Capital's 13F filing for Q2 2018, filed 9 Nov 2018.